0001437749-19-011066.txt : 20190530
0001437749-19-011066.hdr.sgml : 20190530
20190530160314
ACCESSION NUMBER: 0001437749-19-011066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190528
FILED AS OF DATE: 20190530
DATE AS OF CHANGE: 20190530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDOUX MARK A
CENTRAL INDEX KEY: 0001115556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15701
FILM NUMBER: 19866513
MAIL ADDRESS:
STREET 1: 1185 LINDA VISTA DR
CITY: SAN MARCOS
STATE: CA
ZIP: 92069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC
CENTRAL INDEX KEY: 0000787253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 841007839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
BUSINESS PHONE: 6197447340
MAIL ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC
DATE OF NAME CHANGE: 19860929
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-05-28
0000787253
NATURAL ALTERNATIVES INTERNATIONAL INC
NAII
0001115556
LEDOUX MARK A
1535 FARADAY AVENUE
CARLSBAD
CA
92008
1
1
1
CEO/Chairman
Common Stock
2019-05-28
4
D
0
15000
12.65
D
66009
D
Common Stock
2019-05-28
4
D
0
5000
12.65
D
530000
I
By LeDoux Family Limited Partnership
Common Stock
176500
I
By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992
Common Stock
69416
I
By IRA
Common Stock
7200
I
By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock
800
I
By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock
4000
I
By Self as Custodian for Aimee LeDoux
This transaction represents a sale to the Company of 15,000 shares by the Company's CEO, and the sale of 5,000 shares by the affiliated family limited partnership of the CEO, both pursuant to the Company's Stock Repurchase Plan.
The Company paid the purchase price of $12.65 by prior agreement with the Sellers that the price would be $0.25 per share less than the last trade on the Nasdaq market on the trading day prior to the date of the transfer of shares from the reporting persons to the Company.
The sole general partner of the Seller is the CEO of the Company, who also has a beneficial interest as a limited partner.
/s/ Kenneth E Wolf on behalf of Mr. LeDoux pursuant to a Power of Attorney
2019-05-29